TABORSKY, Milos, Tomas SKALA, Marie LAZAROVA, Renata AIGLOVA, Jindřich ŠPINAR, Lenka ŠPINAROVÁ, Jiří VÍTOVEC, Josef KAUTZNER, Vojtech MELENOVSKY, Filip MALEK, Ladislav DUŠEK, Jiří JARKOVSKÝ, Klára BENEŠOVÁ, Marek VICHA and Ales LINHART. Trends in the treatment and survival of heart failure patients: a nationwide population-based study in the Czech Republic. ESC Heart Failure. San Francisco: Wiley Periodicals, 2021, vol. 8, No 5, p. 3800-3808. ISSN 2055-5822. Available from: https://dx.doi.org/10.1002/ehf2.13559.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Trends in the treatment and survival of heart failure patients: a nationwide population-based study in the Czech Republic
Authors TABORSKY, Milos (203 Czech Republic), Tomas SKALA (203 Czech Republic, guarantor), Marie LAZAROVA (203 Czech Republic), Renata AIGLOVA (203 Czech Republic), Jindřich ŠPINAR (203 Czech Republic), Lenka ŠPINAROVÁ (203 Czech Republic), Jiří VÍTOVEC (203 Czech Republic), Josef KAUTZNER (203 Czech Republic), Vojtech MELENOVSKY (203 Czech Republic), Filip MALEK (203 Czech Republic), Ladislav DUŠEK (203 Czech Republic, belonging to the institution), Jiří JARKOVSKÝ (203 Czech Republic, belonging to the institution), Klára BENEŠOVÁ (203 Czech Republic, belonging to the institution), Marek VICHA (203 Czech Republic) and Ales LINHART (203 Czech Republic).
Edition ESC Heart Failure, San Francisco, Wiley Periodicals, 2021, 2055-5822.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30201 Cardiac and Cardiovascular systems
Country of publisher United States of America
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 3.612
RIV identification code RIV/00216224:14110/21:00123118
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.1002/ehf2.13559
UT WoS 000686108700001
Keywords in English Heart failure; Incidence; Prevalence; Treatment; European Union; Czech Republic
Tags 14119612, rivok
Tags International impact, Reviewed
Changed by Changed by: Mgr. Tereza Miškechová, učo 341652. Changed: 6/12/2021 09:26.
Abstract
Aims A retrospective nationwide observational analysis of diagnoses, procedures, and treatment reported to the Czech National Registry of Reimbursed Health Services between 2012 and 2018. Methods and results Prevalence of heart failure (HF) patients increased from 176 496 (1679.4 per 100 000 population) in 2012 to 285 745 (2689.0 per 100 000 population) patients in 2018 (mean age 74.4 +/- 12.8 years). In the last years, a stable incidence of HF patients was observed (544 per 100 000 population in 2016 vs. 551 per 100 000 population in 2018; P = 0.310). Mortality rate decreased from 20.55% in 2012 to 15.89% in 2018. The number of hospitalized patients remained similar (318.2 per 100 000 population in 2012 vs. 311.8 per 100 000 population in 2018; P = 0.479). The most used drugs were diuretics (173 295; 60.6%) and beta-blockers (178 823; 62.6%), followed by angiotensin-converting enzyme inhibitors/angiotensin II receptor blockers (angiotensin-converting enzyme inhibitors 120.581; 42.2%; angiotensin II receptor blockers 47 216; 16.5%). Even though the whole number of implanted devices in HF patients increased steadily (from 25 205 in 2012 to 45 363 in 2018), the prevalence of all devices (pacemakers and defibrillators) in the HF patients remained about the same (14.3% in 2012; 15.9% in 2018). Conclusions The study included all patients with HF in the Czech Republic. These are the first nationwide data of HF epidemiology in the Eastern bloc. The incidence of HF remains stable in the last years. Due to aging of the population, the prevalence of HF significantly increased in the last 6 years. Despite a continuous increase in the prevalence of HF and a suboptimal utilization of its pharmacological therapy, mortality decreased, and the number of hospitalized patients remained the same.
PrintDisplayed: 26/5/2024 23:13